Form 4: Ani Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Nikhil Lalwani, PRESIDENT & CEO and a Director of Ani Pharmaceuticals Inc, sold 5,400 shares of common stock on September 15, 2026 for $71.00 per share.
Summary
- Open-market sale: disposed of 5,400 Common Stock at $71.00 ($383,400) on September 15, 2026; holds 339,089 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $383,400 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Nikhil Lalwani — Director, Officer (PRESIDENT & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Stock | 5,400 | $71 | $383.4K | 339,089 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (5,400 shares) |
Keywords
insider transaction, Form 4, ANIP, ANI PHARMACEUTICALS INC, bearish, Nikhil Lalwani
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.